WEINSTEIN ROBERT — SEC Form 4 filings
SEC reporting owner CIK 1213709. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-07-17 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | Director | 4 | — | — | 6 |
| TAO Synergies Inc. (TAOX) | Chief Financial Officer | 3 | — | — | 6 |
| XWELL, Inc. (XWEL) | Director | 4 | — | — | 5 |
Form 4 filings — WEINSTEIN ROBERT
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2026-07-17 | 4/A | PharmaCyte Biotech, Inc. (PMCB) | Other (J): 0 (derivative) | EDGAR |
| 2026-05-19 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2026-04-02 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 119,170 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-12-12 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 75,000 @ $0 · Tax withholding (F): 33,750 @ $1.02 · Grant/award (A): 63,233 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 10,000 @ $0 · Tax withholding (F): 4,000 @ $7.23 · Grant/award (A): 7,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | TAO Synergies Inc. (TAOX) | Grant/award (A): 15,410 @ $0 · Tax withholding (F): 6,164 @ $7.85 | EDGAR |
| 2025-06-03 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 107,407 · Grant/award (A): 117,886 (derivative) @ $0 | EDGAR |
| 2024-11-18 | 4 | XWELL, Inc. (XWEL) | Grant/award (A): 30,825 (derivative) @ $0 | EDGAR |
| 2024-07-17 | 4 | PharmaCyte Biotech, Inc. (PMCB) | Grant/award (A): 38,009 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1213709 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →